305 related articles for article (PubMed ID: 22595989)
1. Expression of TNFAIP3 in intestinal epithelial cells protects from DSS- but not TNBS-induced colitis.
Rhee L; Murphy SF; Kolodziej LE; Grimm WA; Weber CR; Lodolce JP; Chang JE; Bartulis SJ; Messer JS; Schneider JR; Paski S; Nero TM; Boone DL
Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(2):G220-7. PubMed ID: 22595989
[TBL] [Abstract][Full Text] [Related]
2. Intestinal epithelial expression of TNFAIP3 results in microbial invasion of the inner mucus layer and induces colitis in IL-10-deficient mice.
Murphy SF; Rhee L; Grimm WA; Weber CR; Messer JS; Lodolce JP; Chang JE; Bartulis SJ; Nero T; Kukla RA; MacDougall G; Binghay C; Kolodziej LE; Boone DL
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(9):G871-82. PubMed ID: 25234043
[TBL] [Abstract][Full Text] [Related]
3. PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice.
Qiu W; Wu B; Wang X; Buchanan ME; Regueiro MD; Hartman DJ; Schoen RE; Yu J; Zhang L
J Clin Invest; 2011 May; 121(5):1722-32. PubMed ID: 21490394
[TBL] [Abstract][Full Text] [Related]
4. Raf kinase inhibitor protein mediates intestinal epithelial cell apoptosis and promotes IBDs in humans and mice.
Lin W; Ma C; Su F; Jiang Y; Lai R; Zhang T; Sun K; Fan L; Cai Z; Li Z; Huang H; Li J; Wang X
Gut; 2017 Apr; 66(4):597-610. PubMed ID: 26801887
[TBL] [Abstract][Full Text] [Related]
5. TNFAIP3 maintains intestinal barrier function and supports epithelial cell tight junctions.
Kolodziej LE; Lodolce JP; Chang JE; Schneider JR; Grimm WA; Bartulis SJ; Zhu X; Messer JS; Murphy SF; Reddy N; Turner JR; Boone DL
PLoS One; 2011; 6(10):e26352. PubMed ID: 22031828
[TBL] [Abstract][Full Text] [Related]
6. Novel guggulsterone derivative GG-52 inhibits NF-kappaB signaling in intestinal epithelial cells and attenuates acute murine colitis.
Kim JM; Kang HW; Cha MY; Yoo D; Kim N; Kim IK; Ku J; Kim S; Ma SH; Jung HC; Song IS; Kim JS
Lab Invest; 2010 Jul; 90(7):1004-15. PubMed ID: 20195240
[TBL] [Abstract][Full Text] [Related]
7. The PepT1-NOD2 signaling pathway aggravates induced colitis in mice.
Dalmasso G; Nguyen HT; Ingersoll SA; Ayyadurai S; Laroui H; Charania MA; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2011 Oct; 141(4):1334-45. PubMed ID: 21762661
[TBL] [Abstract][Full Text] [Related]
8. Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.
Kim SW; Kim HM; Yang KM; Kim SA; Kim SK; An MJ; Park JJ; Lee SK; Kim TI; Kim WH; Cheon JH
Inflamm Bowel Dis; 2010 Sep; 16(9):1514-25. PubMed ID: 20310012
[TBL] [Abstract][Full Text] [Related]
9. Tomato lycopene extract prevents lipopolysaccharide-induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice.
Joo YE; Karrasch T; Mühlbauer M; Allard B; Narula A; Herfarth HH; Jobin C
PLoS One; 2009; 4(2):e4562. PubMed ID: 19234608
[TBL] [Abstract][Full Text] [Related]
10. Genetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-κB pathway inflammatory response.
Ghaleb AM; Laroui H; Merlin D; Yang VW
Inflamm Bowel Dis; 2014 May; 20(5):811-20. PubMed ID: 24681655
[TBL] [Abstract][Full Text] [Related]
11. Isosteviol attenuates DSS-induced colitis by maintaining intestinal barrier function through PDK1/AKT/NF-κB signaling pathway.
Yao L; Chen X; Shen M; Zhao Y; Cao Q
Int Immunopharmacol; 2023 Jan; 114():109532. PubMed ID: 36508925
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling.
Qian K; Yuan L; Wang S; Kuang Y; Jin Q; Long D; Jiang Y; Zhao H; Liu K; Yao H
Clin Exp Immunol; 2021 Aug; 205(2):246-256. PubMed ID: 33942299
[TBL] [Abstract][Full Text] [Related]
13. Effect of exogenous galectin-9, a natural TIM-3 ligand, on the severity of TNBS- and DSS-induced colitis in mice.
Xiong H; Xue G; Zhang Y; Wu S; Zhao Q; Zhao R; Zhou N; Xie Y
Int Immunopharmacol; 2023 Feb; 115():109645. PubMed ID: 36610329
[TBL] [Abstract][Full Text] [Related]
14. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis.
Liu W; Chen Y; Golan MA; Annunziata ML; Du J; Dougherty U; Kong J; Musch M; Huang Y; Pekow J; Zheng C; Bissonnette M; Hanauer SB; Li YC
J Clin Invest; 2013 Sep; 123(9):3983-96. PubMed ID: 23945234
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice.
Chun J; Lee C; Hwang SW; Im JP; Kim JS
Life Sci; 2014 Aug; 110(1):23-34. PubMed ID: 24992474
[TBL] [Abstract][Full Text] [Related]
16. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis.
Darnaud M; Dos Santos A; Gonzalez P; Augui S; Lacoste C; Desterke C; De Hertogh G; Valentino E; Braun E; Zheng J; Boisgard R; Neut C; Dubuquoy L; Chiappini F; Samuel D; Lepage P; Guerrieri F; Doré J; Bréchot C; Moniaux N; Faivre J
Gastroenterology; 2018 Mar; 154(4):1009-1023.e14. PubMed ID: 29133078
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of NF-κB in Intestinal Epithelial Cells Is Sufficient to Mitigate the Bone Loss Comorbidity of Experimental Mouse Colitis.
Ke K; Chen TH; Arra M; Mbalaviele G; Swarnkar G; Abu-Amer Y
J Bone Miner Res; 2019 Oct; 34(10):1880-1893. PubMed ID: 31107556
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium chloride improves the course of TNBS and DSS-induced colitis through protecting against colonic mucosal inflammation.
Du C; Wang P; Yu Y; Chen F; Liu J; Li Y
Sci Rep; 2014 Aug; 4():6096. PubMed ID: 25146101
[TBL] [Abstract][Full Text] [Related]
19. Epithelial PBLD attenuates intestinal inflammatory response and improves intestinal barrier function by inhibiting NF-κB signaling.
Chen S; Liu H; Li Z; Tang J; Huang B; Zhi F; Zhao X
Cell Death Dis; 2021 May; 12(6):563. PubMed ID: 34059646
[TBL] [Abstract][Full Text] [Related]
20. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
